Intravenous |
Fastest onset of action
No bioavailability concerns
Bypass first-pass metabolism
Large volume can be administered
Reliable route for sedated or comatose patients
|
Highly trained individuals required to administer
May require physical restraint
Injection site irritation, extravasation, or infection
Development of tolerance with continuous infusions
|
Intramuscular |
|
Trained individuals required to administer
May require physical restraint
Painful
Variable absorption
Injection site irritation or infection
Limited volume can be administered (2–5 mL)
|
Intranasal |
|
|
Buccal and Sublingual |
|
|
Rectal |
|
|